ASCRS FDA Committee Member Damien Goldberg, MD, Urges FDA to Allow Access to Compounded Drugs from Traditional Compounders Without a Patient-Specific Prescription

During an FDA public meeting this week, Damien Goldberg, MD, a member of the AS


Ocular Science Launches Two Affiliates to Focus on Compounding and Biologic Sectors of Ophthalmic Market

Ocular Science has divided its Southern California-based operation into two standalone C corporations: OSRX, Inc., the company’s 503A com